$SNPS

The Market May Be Underestimating This AI Chip-Design Stock

Synopsys (SNPS) reported Q3 revenue of $2.477B, up 42.37% YoY, with EPS of $3.91. Management raised full-year guidance. Analysts set a $552.60 price target, +24.85% upside, citing AI-driven growth and Ansys integration. Risks include debt and export controls. SNPS trades at a lower P/E than peers Cadence (CDNS) and Autodesk (ADSK).

Original reporting
Published Sep 1, 2026, 2:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 1, 2026, 3:05 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
The Market May Be Underestimating This AI Chip-Design Stock — source image
Decision brief

The 30-second read

$SNPSBullishHigh
01

Why it matters

The beat and raised guidance could trigger a re‑rating by analysts and attract momentum traders.

02

Market read

Earnings beat and guidance raise Synopsys' upside, with spillover to the AI‑hardware ecosystem.

03

What to watch

If AI workflow adoption slows or integration costs rise, guidance may be unsustainable.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

Synopsys is a leading EDA provider; its earnings are closely watched for AI‑related growth.

Company-level read

Ticker impact

$SNPSBullishHigh confidence
Context

Synopsys reported Q3 FY26 earnings beating estimates and raised full-year revenue and EPS guidance.

Expected impact

Potential price appreciation toward the $552 target.

Evidence & confidence

Strong revenue growth, AI workflow synergies, and a valuation gap versus peers support a bullish outlook.

Market effects

Positive earnings may lift the broader EDA sector and AI‑related hardware stocks.

U.S. tech sector gains expected.

Highlights AI‑driven design demand worldwide.

Counterpoint

Risks include high debt from the Ansys acquisition and potential export‑control constraints on China.

Key entities

  • Synopsys

    EDA software leader reporting earnings.

Related articles

$SNPSMedAI 8/10

Why Has Synopsys Stopped Leading With Bad News?

Synopsys (SNPS) shifted its earnings call focus from past issues, like China's export restrictions and IP business underperformance, to new growth areas like Multiphysics Fusion with Ansys and agentic AI. Design Automation grew to $7.7-7.9B, while Design IP remained at $1.8B. Management expects new initiatives to boost EDA growth in 2027, but Design IP's turnaround is based on a single quarter of growth.

$SNPSMed

SNPS Upgraded by Morgan Stanley -- Price Target Maintained at $5

Morgan Stanley upgraded Synopsys (SNPS) to Overweight, maintaining a $500 price target. The stock is trading at $396.11, which is 39.9% undervalued according to its GF Value™ of $659.20. Synopsys has a GF Score™ of 88/100, indicating strong growth potential but concerns about valuation. Insider activity shows significant selling, with $40.7 million in sales over the last three months.

$SNPSMedAI 9/10

How to Play SNPS Stock as Layoffs Hit Synopsys

Synopsys (SNPS) reported Q3 FY2026 earnings with revenue of $2.48B, up 42.4% YoY, and EPS of $3.91, beating estimates. The company raised its full-year outlook. Analysts maintain 'Buy' ratings with price targets up to $633, citing long-term growth potential in semiconductor design.